Loading...
XSHE000972
Market cap314mUSD
Dec 27, Last price  
2.98CNY
1D
4.93%
1Q
9.56%
Jan 2017
-57.43%
Name

Chalkis Health Industry Co Ltd

Chart & Performance

D1W1MN
XSHE:000972 chart
P/E
21.23
P/S
3.99
EPS
0.14
Div Yield, %
0.72%
Shrs. gr., 5y
0.06%
Rev. gr., 5y
-1.68%
Revenues
576m
-2.29%
695,720,0731,030,318,9491,532,717,7532,142,790,1151,967,529,6281,660,020,9911,511,963,5701,424,785,5351,245,962,132954,944,330416,772,255682,896,707588,176,013517,710,604626,669,589213,188,82622,966,067174,451,612589,285,550575,779,449
Net income
108m
+314.94%
53,262,40848,715,418056,047,527027,774,8540064,021,480011,269,9420026,583,87104,975,7790026,085,146108,237,777
CFO
-182m
L
42,869,804170,476,28165,019,714223,877,976144,722,3880000345,338,7290000416,334,994142,656,99500197,747,426-182,233,893
Dividend
Jun 10, 20080.03 CNY/sh
Earnings
Apr 11, 2025

Profile

Chalkis Health Industry Co., Ltd. produces, processes, and sells tomatoes worldwide. It offers tomato paste concentrated in drums and wooden bins, peeled and diced tomatoes, canned tomato products, tomato fiber sheets, and tomato seed oil, as well as lycopene capsules. The company was formerly known as Xinjiang Chalkis Co., Ltd. and changed its name to Chalkis Health Industry Co., Ltd. in May 2016. Chalkis Health Industry Co., Ltd. is based in Urumqi, China.
URL
http://www.chalkistomato.com/
IPO date
Sep 26, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
575,779
-2.29%
589,286
237.79%
174,452
659.61%
Cost of revenue
452,399
446,520
180,030
Unusual Expense (Income)
NOPBT
123,380
142,765
(5,578)
NOPBT Margin
21.43%
24.23%
Operating Taxes
219
5,291
Tax Rate
0.18%
3.71%
NOPAT
123,161
137,474
(5,578)
Net income
108,238
314.94%
26,085
 
Dividends
(16,468)
(12,913)
Dividend yield
0.60%
0.59%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
345,709
12,326
18,387
Long-term debt
72,891
Deferred revenue
16,900
2,405
2,724
Other long-term liabilities
125,665
130,589
Net debt
304,066
(195,145)
(2,130)
Cash flow
Cash from operating activities
(182,234)
197,747
CAPEX
(214,935)
Cash from investing activities
(216,704)
Cash from financing activities
322,245
180,880
FCF
(152,590)
123,303
107,098
Balance
Cash
110,646
207,472
20,517
Long term investments
3,888
1
Excess cash
85,745
178,007
11,795
Stockholders' equity
(898,625)
1,344,288
1,344,289
Invested Capital
1,543,193
45,514
212,196
ROIC
15.50%
106.69%
ROCE
19.14%
63.87%
EV
Common stock shares outstanding
773,127
771,284
771,284
Price
3.55
25.89%
2.82
4.83%
2.69
17.47%
Market cap
2,744,601
26.19%
2,175,020
4.83%
2,074,753
17.47%
EV
3,054,581
1,984,981
2,077,730
EBITDA
164,284
187,541
40,061
EV/EBITDA
18.59
10.58
51.86
Interest
22,072
15,870
10,290
Interest/NOPBT
17.89%
11.12%